PETALING JAYA: The healthcare sector can look forward to a resilient earnings in 2023, particularly among players in the private hospitals, pharmaceuticals and over-the-counter (OTC) drugs as well as immunotherapy.
“Growth prospects for the sector in the long-term will continue to be underpinned by an ageing population, rising affluence and growing chronic diseases across the globe such as cardiovascular, cancer and respiratory,” said Kenanga Research in its latest report.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
